Target Name: LOC107986453
NCBI ID: G107986453
Review Report on LOC107986453 Target / Biomarker Content of Review Report on LOC107986453 Target / Biomarker
LOC107986453
Other Name(s): Uncharacterized protein LOC107986453 (isoform X2) | CTC-321K16.1 | uncharacterized LOC107986453 | Uncharacterized LOC107986453, transcript variant X3 | LOC107986453 variant X3

LOC107986453: A Potential Drug Target Or Biomarker

LOC107986453 (Uncharacterized protein LOC107986453 (isoform X2)) is a protein that has been identified as a potential drug target or biomarker. The protein is derived from the Uncharacterized protein LOC107986453 (isoform X2) gene, which is located on chromosome 16 at position 188.850 GCA.

LOC107986453 (Uncharacterized protein LOC107986453 (isoform X2)) is a protein that is expressed in a variety of tissues, including the brain, heart, and kidneys. It is also highly expressed in the placenta, which is a vital organ that plays a critical role in the development and maintenance of fetal tissue.

One of the key features of LOC107986453 (Uncharacterized protein LOC107986453 (isoform X2)) is its unique structure. The protein has a molecular weight of 41.1 kDa and a calculated pI of 11.95. It is a monomeric protein that consists of a single polypeptide chain that is composed of 20 amino acid residues.

The unique structure of LOC107986453 (Uncharacterized protein LOC107986453 (isoform X2)) makes it a potential drug target or biomarker. One of the key advantages of targeting this protein is its high expression level in a variety of tissues, which could make it an effective target for drugs that are effective in these tissues. Additionally, the protein's high pI suggests that it is a stable protein that is resistant to changes in pH, which could make it an effective target for drugs that are able to alter protein stability.

Another potential advantage of LOC107986453 (Uncharacterized protein LOC107986453 (isoform X2)) as a drug target or biomarker is its involvement in a variety of physiological processes. The protein is involved in the regulation of cell adhesion, which is a critical process that helps maintain the integrity of tissues. It is also involved in the regulation of the immune response, which is a critical process that helps protect the body against infection and disease.

In addition to its potential role in drug targeting and biomarker development, LOC107986453 (Uncharacterized protein LOC107986453 (isoform X2)) is also a potential target for small molecules. Many drugs that are currently in use are small molecules that are able to interact with specific proteins, including LOC107986453 (Uncharacterized protein LOC107986453 (isoform X2)). By using small molecules to interact with LOC107986453 (Uncharacterized protein LOC107986453 (isoform X2)), it may be possible to develop new treatments for a variety of diseases.

Overall, LOC107986453 (Uncharacterized protein LOC107986453 (isoform X2)) is a protein that has the potential to be a drug target or biomarker. Its unique structure and high expression level in a variety of tissues make it an attractive target for drugs that are effective in these tissues. Additionally, its involvement in a variety of physiological processes makes it a potential target for small molecules, which could be used to develop new treatments for a variety of diseases. Further research is needed to determine the full potential of LOC107986453 (Uncharacterized protein LOC107986453 (isoform X2)) as a drug target or biomarker.

Protein Name: Uncharacterized LOC107986453

The "LOC107986453 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC107986453 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC107986454 | LOC107986469 | LOC107986517 | LOC107986522 | LOC107986528 | LOC107986537 | LOC107986544 | LOC107986545 | LOC107986561 | LOC107986589 | LOC107986594 | LOC107986595 | LOC107986597 | LOC107986598 | LOC107986606 | LOC107986613 | LOC107986622 | LOC107986623 | LOC107986626 | LOC107986636 | LOC107986649 | LOC107986666 | LOC107986764 | LOC107986766 | LOC107986770 | LOC107986771 | LOC107986772 | LOC107986774 | LOC107986776 | LOC107986777 | LOC107986781 | LOC107986787 | LOC107986800 | LOC107986816 | LOC107986820 | LOC107986836 | LOC107986844 | LOC107986873 | LOC107986892 | LOC107986894 | LOC107986901 | LOC107986903 | LOC107986927 | LOC107986930 | LOC107986952 | LOC107986961 | LOC107986983 | LOC107986996 | LOC107987026 | LOC107987045 | LOC107987049 | LOC107987053 | LOC107987057 | LOC107987064 | LOC107987087 | LOC107987099 | LOC107987121 | LOC107987164 | LOC107987178 | LOC107987211 | LOC107987243 | LOC107987249 | LOC107987251 | LOC107987282 | LOC107987285 | LOC107987299 | LOC107987301 | LOC107987304 | LOC107987407 | LOC107987412 | LOC107987429 | LOC107987435 | LOC107987440 | LOC107987443 | LOC107987449 | LOC107987453 | LOC107987459 | LOC112267867 | LOC112267881 | LOC112267902 | LOC112267956 | LOC112267962 | LOC112267968 | LOC112267978 | LOC112268051 | LOC112268136 | LOC112268248 | LOC112268286 | LOC112268294 | LOC112268416 | LOC114224 | LOC123862 | LOC124901339 | LOC126987 | LOC129026 | LOC132386 | LOC143666 | LOC145474 | LOC145845 | LOC148430